InsidersTradesSigma
Browse the complete record of transactions filed by Young Rodney KB, Chief Financial Officer. Director active across 1 company, notably RAPT Therapeutics, Inc.. In total, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €50k. Activity tracked since 10 May 2022. The latest transaction was filed on 10 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Rodney KB Young is the Chief Financial Officer of RAPT Therapeutics, Inc. He is responsible for the company's financial management, including financial planning, risk management, and performance analysis. His financial expertise is essential to support the strategic objectives of RAPT Therapeutics, Inc.